Table 1 Baseline characteristics of the study population

Age (years)

34.90 ± 10.77

36.77 ± 11.00

0.509^a

Sex n (%)

Female

9 (30%)

9 (30%)

0.99^b

Male

21(70%)

21(70%)

Weight (kg)

74.43 ± 14.98

71.67 ± 11.58

0.427^a

Height (cm)

168.93 ± 9.23

171.17 ± 7.62

0.311^a

BMI (kg/m²)

26.23 ± 5.57

24.43 ± 3.51

0.141^a

TBSA (%)

48.17 ± 9.87

44.27 ± 10.45

0.143^a

Burn degree

n (%)

2nd degree

7 (23.3%)

7 (23.3%)

0.641

3rd degree

6 (20%)

9 (30%)

2nd and 3rd degree

17 (56.7%)

14 46.7(%)

Cause n (%)

Flame

28 (93.3%)

23 (76.7%)

0.145^b

Others^c

2 (6.7%)

7 (23.3%)

Comorbidities

n (%)

No

24 (80%)

25 (83.3%)

0.99^b

Yes

Total

6 (20%)

5 (16.7%)

Hypertension

4 (13.3%)

0

Hyperlipidemia

0

1 (3.3%)

Hypertension-kidney disease

0

1 (3.3%)

Lung disease

1 (3.3%)

2 (6.7%)

Hypothyroidism

1 (3.3%)

0

Diabetes

0

1 (3.3%)

Protein intake (g/d)

142.27 ± 21.68

136.47 ± 16.90

0.253^a

Energy intake (kcal/day)

3170.00 ± 557.18

2934.50 ± 555.27

0.106^a

Supplement intake

n (%)

Vitamin C

30 (100%)

30 (100%)

-

Vitamin A

27 (90%)

26 (86.7%)

0.99^b

Vitamin D

30 (100%)

30 (100%)

-

Vitamin E

27 (90%)

26 (86.7%)

0.99^b

Vitamin B6

8 (26.7%)

5 (16.7%)

0.532^b

Vitamin B1

8 (26.7%)

13 (43.3%)

0.279^b

B-complex^d

30 (100%)

30 (100%)

-

Selenium

26 (86.7%)

22 (73.3%)

0.333^b

Zinc

30 (100%)

28 (93.3%)

0.492^b

Omega-3

15 (50%)

12 (40%)

0.604^b

Ferfolic^e

17 (56.7%)

23 (76.7%)

0.170^b

Heallagen^f

17 (56.7%)

14 (46.7%)

0.606^b

Albumin

20 (66.7%)

23 (76.7%)

0.567^b

Drug intake

n (%)

Corticosteroids

16 (53.3%)

17 (56.7%)

0.99^b

NSAIDs

15 (50%)

17 (56.7%)

0.796^b

Statins

2 (6.7%)

1 (3.3%)

0.99^b